Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07855835). This is a study registration, not published results. Lead sponsor: Bezmialem Vakif University. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 72 participants (ACTUAL). Conditions: Central Venous Catheter Care. Interventions: DEVICE: Skin Protective Barrier Film; OTHER: Standard Central Venous Catheter Dressing Care. Primary outcome measures: Change in Central Venous Catheter Insertion-Site Skin Integrity From Baseline to Day 7 , Baseline (T0) and Day 7 (T1). Brief summary: This randomized controlled study evaluated the effectiveness of a skin protective barrier film used during central venous catheter (CVC) care in adult intensive care unit patients. A total of 72 patients with a CVC were randomly assigned in a 1:1 ratio to an intervention group or a control group. In the intervention group, a skin protective barrier film was applied during CVC dressing care in addition to the standard care procedure. The control group received standard CVC dressing care without the skin protective barrier film. Patients were followed for seven days. Dressing integrity, skin integrity at the catheter insertion site, presence and type of drainage, signs of infection, and central line-associated bloodstream infection were evaluated. The study aimed to determine whether the use of a skin protective barrier film during CVC care contributes to maintaining skin and dressing integrity and affects catheter-related complications.